DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Sharma M, Molina CA, Toyoda K. et al.
Rationale and design of the AXIOMATIC-SSP phase II trial: antithrombotic treatment with factor XIa inhibition to optimize management of acute thromboembolic events for secondary stroke prevention.
J Stroke Cerebrovasc Dis 2022;
31 (10) 106742
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.